Dermatology Times, August 2021 (Vol. 42, No. 8)

In this month's Legal Eagle column, David J. Goldberg, MD, JD, explores selling your practice to a private equity interest and the challenges that can follow, including staff shortages and longer patient wait times.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explores the world of hair, including ammonia-free hair dyes, how conditioner can prevent hair breakage, hair oiling, and more.

It has been 20 years since the FDA approved a new sunscreen filter. However, a recent study evaluating curcumin could change that.

There are an increasing number of novel immunotherapies available for patients with skin cancer, however, their numerous adverse events must be addressed.

The share of physicians in private practice has dropped below 50 percent.

Curcumin has a long history as an effective treatment for everything from chronic pain to skin infections. Nanoparticle encapsulation shows promise in meeting that challenge and opening the way for a safe, effective adjuvant to sunscreen.

Novel inhibitor of the 26S proteasome was found to be safe, well-tolerated, and effective in reducing inflammatory lesions and erythema in patients with rosacea.

Do COVID-19 antigens cause hypersensitivity to dermal fillers?

Vector-borne infectious diseases are spreading and skin cancer is rising because of climate change.

Ritlecitinib, an investigational covalent kinase inhibitor, achieved its primary endpoint and demonstrated statistically significant efficacy compared to placebo in treating alopecia areata.

Here are best practices in understanding scar morphology, building patient trust, and choosing treatment.

As COVID-19 eases, the FDA is breaking through its backlog and clinical trials are moving forward, opening the way for a new wave of treatments.

Investigators show that both terms tend to be used in different contexts within the biomedical literature.

New study data presented at EADV demonstrated an association between COVID-19 severity in male patients and the sex hormone androgen.